- Home
- MARPS vs NURO Comparison
MARPS vs NURO Comparison
Compare MARPS & NURO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MARPS
- NURO
- Stock Information
- Founded
- MARPS 1956
- NURO 1996
- Country
- MARPS United States
- NURO United States
- Employees
- MARPS N/A
- NURO N/A
- Industry
- MARPS Oil & Gas Production
- NURO Medical/Dental Instruments
- Sector
- MARPS Energy
- NURO Health Care
- Exchange
- MARPS Nasdaq
- NURO Nasdaq
- Market Cap
- MARPS 7.9M
- NURO 8.2M
- IPO Year
- MARPS N/A
- NURO N/A
- Fundamental
- Price
- MARPS $4.10
- NURO $4.42
- Analyst Decision
- MARPS
- NURO
- Analyst Count
- MARPS 0
- NURO 0
- Target Price
- MARPS N/A
- NURO N/A
- AVG Volume (30 Days)
- MARPS 29.2K
- NURO 14.4K
- Earning Date
- MARPS 01-01-0001
- NURO 11-01-2024
- Dividend Yield
- MARPS 8.19%
- NURO N/A
- EPS Growth
- MARPS N/A
- NURO N/A
- EPS
- MARPS 0.36
- NURO N/A
- Revenue
- MARPS $1,044,997.00
- NURO $4,383,614.00
- Revenue This Year
- MARPS N/A
- NURO N/A
- Revenue Next Year
- MARPS N/A
- NURO N/A
- P/E Ratio
- MARPS $11.36
- NURO N/A
- Revenue Growth
- MARPS N/A
- NURO N/A
- 52 Week Low
- MARPS $3.77
- NURO $2.66
- 52 Week High
- MARPS $6.50
- NURO $5.60
- Technical
- Relative Strength Index (RSI)
- MARPS 49.68
- NURO 65.06
- Support Level
- MARPS $3.98
- NURO $3.96
- Resistance Level
- MARPS $4.19
- NURO $4.69
- Average True Range (ATR)
- MARPS 0.20
- NURO 0.22
- MACD
- MARPS -0.02
- NURO 0.04
- Stochastic Oscillator
- MARPS 14.63
- NURO 82.35
About MARPS Marine Petroleum Trust Units of Beneficial Interest
Marine Petroleum Trust is a U.S based royalty trust. It provides administration and liquidation of rights to payments from oil and natural gas leases in the Gulf of Mexico. The Trust's subsidiary holds title to interests in properties which are situated offshore of Louisiana. The revenues of the trust are derived from the oil and natural gas production activities of third parties.
About NURO NeuroMetrix Inc.
NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.